Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 9
Results: 13
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1537, doi. 10.1007/s00262-019-02387-9
- By:
- Publication type:
- Article
Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1527, doi. 10.1007/s00262-019-02386-w
- By:
- Publication type:
- Article
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1515, doi. 10.1007/s00262-019-02385-x
- By:
- Publication type:
- Article
Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1501, doi. 10.1007/s00262-019-02384-y
- By:
- Publication type:
- Article
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1547, doi. 10.1007/s00262-019-02383-z
- By:
- Publication type:
- Article
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1493, doi. 10.1007/s00262-019-02382-0
- By:
- Publication type:
- Article
Melanoma-conditioned medium promotes cytotoxic immune responses by murine bone marrow-derived monocytes despite their expression of 'M2' markers.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1455, doi. 10.1007/s00262-019-02381-1
- By:
- Publication type:
- Article
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1479, doi. 10.1007/s00262-019-02380-2
- By:
- Publication type:
- Article
A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1429, doi. 10.1007/s00262-019-02379-9
- By:
- Publication type:
- Article
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1443, doi. 10.1007/s00262-019-02378-w
- By:
- Publication type:
- Article
Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1417, doi. 10.1007/s00262-019-02377-x
- By:
- Publication type:
- Article
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1401, doi. 10.1007/s00262-019-02376-y
- By:
- Publication type:
- Article
Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1467, doi. 10.1007/s00262-019-02375-z
- By:
- Publication type:
- Article